Events, By Category and Date:» Go to news main
The ethical dimensions of new human gene editing technology
Françoise Baylis presents an invited talk to the AAAS 2016 Annual Meeting. 12 February 2016 (15-16:30), Marshall Ballroom North, Marriott Wardman Park, Washington DC.
The discussion of CRISPR-Cas9 should not take place in a vacuum. It must be understood in the context of a rich history of ethical and philosophical scholarship about the relation of science to society, about the control of new technology, about various national and religious ethical traditions, and about how society has responded to a large number of other novel and powerful technologies.
- What Is It Going to Take to End the Pandemic?
- CRISPR‑Cas9 and the Theo‑Ethics of Gene Editing
- Dal Bioethicist Named to Committee that Will Shape Global Summit and Discussion on Human Genome Editing
- International Science Council Board
- Heritable Human Genome Editing: Who Decides? Science or Society?
- Proof of Vaccination/Vaccine Passport Town Hall
- Why Cities Like Boston Shouldn't Follow New York's Lead on Vaccination Passports
- Optimizing the Data Available via Health Canada's Clinical Information Portal